A. Glacet–Bernard

3.1k total citations · 2 hit papers
100 papers, 2.3k citations indexed

About

A. Glacet–Bernard is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, A. Glacet–Bernard has authored 100 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Ophthalmology, 52 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in A. Glacet–Bernard's work include Retinal Diseases and Treatments (61 papers), Retinal and Optic Conditions (40 papers) and Retinal Imaging and Analysis (28 papers). A. Glacet–Bernard is often cited by papers focused on Retinal Diseases and Treatments (61 papers), Retinal and Optic Conditions (40 papers) and Retinal Imaging and Analysis (28 papers). A. Glacet–Bernard collaborates with scholars based in France, Switzerland and Ivory Coast. A. Glacet–Bernard's co-authors include G. Coscas, Eric H. Souied, Florence Coscas, G. Soubrane, Alexandra Mière, Alexandre Sellam, F. Lelong, A. Chabanel, G Coscas and Mathilde Goudot and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

A. Glacet–Bernard

98 papers receiving 2.2k citations

Hit Papers

Normative Data for Vascular Density in Superficial and De... 2015 2026 2018 2022 2016 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Glacet–Bernard France 23 2.0k 1.4k 270 223 141 100 2.3k
Fabio Scarinci Italy 20 1.4k 0.7× 1.1k 0.8× 115 0.4× 169 0.8× 63 0.4× 79 1.6k
Susana Noval Spain 18 830 0.4× 375 0.3× 214 0.8× 154 0.7× 113 0.8× 66 1.1k
Gema Rebolleda Spain 27 1.9k 0.9× 933 0.7× 462 1.7× 127 0.6× 183 1.3× 144 2.2k
Luisa Pierro Italy 26 2.0k 1.0× 1.4k 1.0× 154 0.6× 509 2.3× 188 1.3× 112 2.3k
Florence Coscas France 27 2.8k 1.4× 2.3k 1.6× 99 0.4× 274 1.2× 283 2.0× 103 3.0k
Masoud Aghsaei Fard Iran 22 1.0k 0.5× 486 0.4× 309 1.1× 98 0.4× 78 0.6× 92 1.3k
Divakar Gupta United States 15 523 0.3× 339 0.2× 84 0.3× 170 0.8× 46 0.3× 41 905
Nariman Nassiri United States 20 824 0.4× 738 0.5× 57 0.2× 77 0.3× 31 0.2× 70 1.2k
Tatsuhiko Sato Japan 20 1.2k 0.6× 1.3k 1.0× 166 0.6× 254 1.1× 40 0.3× 62 1.7k
Moshe Snir Israel 21 438 0.2× 472 0.3× 183 0.7× 65 0.3× 11 0.1× 70 1.1k

Countries citing papers authored by A. Glacet–Bernard

Since Specialization
Citations

This map shows the geographic impact of A. Glacet–Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Glacet–Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Glacet–Bernard more than expected).

Fields of papers citing papers by A. Glacet–Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Glacet–Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Glacet–Bernard. The network helps show where A. Glacet–Bernard may publish in the future.

Co-authorship network of co-authors of A. Glacet–Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of A. Glacet–Bernard. A scholar is included among the top collaborators of A. Glacet–Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Glacet–Bernard. A. Glacet–Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glacet–Bernard, A., et al.. (2023). Branch retinal vein occlusion secondary to hormone replacement therapy in a transgender woman. Journal Français d Ophtalmologie. 46(2). 148–151. 4 indexed citations
2.
Nghiem‐Buffet, Sylvia, et al.. (2018). Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion. Journal of Ophthalmology. 2018. 1–5. 2 indexed citations
3.
Jonas, Jost B., Jordi Monés, A. Glacet–Bernard, & G. Coscas. (2017). Retinal Vein Occlusions. Developments in ophthalmology. 58. 139–167. 65 indexed citations
4.
Coscas, Florence, et al.. (2017). OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN RETINAL VEIN OCCLUSION. Retina. 38(8). 1562–1570. 77 indexed citations
5.
Sellam, Alexandre, A. Glacet–Bernard, Florence Coscas, & Eric H. Souied. (2017). Trouble de la perfusion artérielle rétinienne et tomographie en cohérence optique-angiographie. Journal Français d Ophtalmologie. 40(5). 353–362. 11 indexed citations
6.
Glacet–Bernard, A., et al.. (2016). Anti-VEGF treatment of macular edema using a treat-and-extend regimen in retinal vein occlusion in clinical practice. Investigative Ophthalmology & Visual Science. 57(12). 4158–4158. 1 indexed citations
7.
Sellam, Alexandre, A. Glacet–Bernard, Florence Coscas, et al.. (2016). QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF. Retina. 37(6). 1176–1184. 51 indexed citations
8.
Glacet–Bernard, A., et al.. (2014). Rheopheresis in the treatment of non-exudative AMD. Investigative Ophthalmology & Visual Science. 55(13). 5209–5209. 1 indexed citations
10.
Glacet–Bernard, A., et al.. (2010). Underlying Conditions Associated to the Occurrence of Retinal Vein Occlusion. Investigative Ophthalmology & Visual Science. 51(13). 3543–3543. 1 indexed citations
11.
Glacet–Bernard, A., S. Lasry, B. Housset, et al.. (2009). Sleep Apnea Syndrom and Retinal Vein Occlusion : About 33 Patients. Investigative Ophthalmology & Visual Science. 50(13). 394–394. 3 indexed citations
12.
Glacet–Bernard, A., M. Voigt, G. Coscas, & G. Soubrane. (2007). FULL-THICKNESS MACULAR HOLE FOLLOWING INTRAVITREAL INJECTION OF TRIAMCINOLONE ACETONIDE IN CENTRAL RETINAL VEIN OCCLUSION. Retinal Cases & Brief Reports. 1(2). 62–64. 9 indexed citations
13.
Trinh, L., et al.. (2006). Pli maculaire compliquant la chirurgie du décollement de rétine. Journal Français d Ophtalmologie. 29(9). 995–999. 15 indexed citations
14.
Zourdani, Alain, A. Glacet–Bernard, G. Coscas, & G. Soubrane. (2003). Les rétinopathies vasculaires en dehors du diabète. Sang thrombose vaisseaux. 15(6). 291–305.
15.
Glacet–Bernard, A., et al.. (2002). IMAGING ANALYSIS WITH OPTICAL COHERENCE TOMOGRAPHY. Retina. 22(2). 192–201. 10 indexed citations
16.
Glacet–Bernard, A., et al.. (2002). Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. American Journal of Ophthalmology. 133(4). 530–536. 40 indexed citations
17.
Glacet–Bernard, A., et al.. (2001). Effect of isovolemic hemodilution in central retinal vein occlusion. Graefe s Archive for Clinical and Experimental Ophthalmology. 239(12). 909–914. 46 indexed citations
18.
Glacet–Bernard, A., G. Coscas, & G. Soubrane. (1999). Les occlusions veineuses rétiniennes. Sang thrombose vaisseaux. 10(10). 642–650. 1 indexed citations
19.
Glacet–Bernard, A., et al.. (1994). A Randomized, Double-Masked Study on the Treatment of Retinal Vein Occlusion With Troxerutin. American Journal of Ophthalmology. 118(4). 421–429. 67 indexed citations
20.
Gaudric, Alain, et al.. (1992). Quantification of Angiogenesis due to Basic Fibroblast Growth Factor in a Modified Rabbit Corneal Model. Ophthalmic Research. 24(3). 181–188. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026